Insight
Nico Gagelmann
Nico Gagelmann/X

Nico Gagelmann: Methodological challenges in the development of endpoints for myelofibrosis clinical trials

Nico Gagelmann, shared on their X/Twitter:

”Finally out. Methodological challenges in the development of endpoints for myelofibrosis clinical trials.”

Nico Gagelmann: Methodological challenges in the development of endpoints for myelofibrosis clinical trials

Proceed to the article.
Source: Nico Gagelmann/X

cancer clinical research clinical trials drug development EBMT European Society for Blood and Marrow Transplantation Medical Research Methodological Challenges myelofibrosis Nico Gagelmann OncoDaily Oncology